Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer

被引:4
|
作者
Mills, J. [1 ]
Haviland, J. S. [1 ]
Moynihan, C. [2 ]
Bliss, J. M. [1 ]
Hopwood, P. [1 ]
机构
[1] Inst Canc Res, Div Clin Studies, ICR Clin Trials & Stat Unit ICR CTSU, London, England
[2] Inst Canc Res, Dept Genet & Oncol, London, England
基金
英国医学研究理事会;
关键词
Breast cancer; clinical trials; contextual factors; patients'free-text comments; quality of life; radiotherapy; REPORTED OUTCOME MEASURES; EUROPEAN-ORGANIZATION; PATIENT; SURVIVORS; COMORBIDITY; IMPACT; PREDICTORS; STRESS; COHORT; CARE;
D O I
10.1016/j.clon.2018.03.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Exploratory analysis of patients' unsolicited written comments in the first 2 years of the Standardisation of Breast Radiotherapy (START) trial quality of life study highlighted a potential effect of non-treatment-related problems on the ratings and interpretation of patient self-reported questionnaires. At 5 years of follow-up all eligible subjects were invited to write comments to further explore these findings. Materials and methods: Using inductive qualitative methods informed by the exploratory analysis, comments were allocated to relevant themes. Key patientreported outcome measures (PROMS), clinical and demographic factors were collated for patients who did and did not comment at 5 years and comparisons between the groups explored. Results: Of 2208 women completing baseline PROMS, 482 proffered comments from 0 to 24 months, forming nine distinct themes, including chronic conditions, life events and psychosocial concerns. At 5 years, 1041/1727 (60.3%) women contributed comments, of whom 500 randomly selected participants formed the sample for analysis. Findings revealed comorbidity, impaired physical functioning and psychosocial problems as key themes, with prevalent adverse effects from local and systemic treatments. Eight new themes emerged at 5 years, including ageing, concerns about future cancer and positive aspects of care. Women commenting were better educated, slightly older and more likely to have had chemotherapy compared with non-commenters. They had significantly worse PROM scores for global health and key quality of life domains relevant to the difficulties they revealed. Conclusions: Difficult personal circumstances and other health concerns affected many women's PROM ratings at 5 years of follow-up, in addition to ongoing cancer treatment effects. Greater attention to multiple sources of distress and adversity could facilitate personalised care and aid interpretation of PROMS. (C) 2018 The Royal College of Radiologists. Published by Elsevier Ltd.
引用
收藏
页码:433 / 441
页数:9
相关论文
共 34 条
  • [1] The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: Results from the UK Standardisation of Radiotherapy Trials (START)
    Hopwood, Penelope
    Sumo, Georges
    Mills, Judith
    Haviland, Joanne
    Bliss, Judith M.
    BREAST, 2010, 19 (02) : 84 - 91
  • [2] Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation
    Haviland, Joanne S.
    Bentzen, Soren M.
    Bliss, Judith M.
    Yarnold, John R.
    RADIOTHERAPY AND ONCOLOGY, 2016, 121 (03) : 420 - 423
  • [3] The impact of age and clinical factors on quality of life in early breast cancer: An analysis of 2208 women recruited to the UKSTART Trial (Standardisation of Breast Radiotherapy Trial)
    Hopwood, Penelope
    Haviland, Joanne
    Mills, Judith
    Sumo, Georges
    Bliss, Judith M.
    BREAST, 2007, 16 (03) : 241 - 251
  • [4] Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials
    Haviland, Joanne S.
    Mannino, Mariella
    Griffin, Clare
    Porta, Nuria
    Sydenham, Mark
    Bliss, Judith M.
    Yarnold, John R.
    RADIOTHERAPY AND ONCOLOGY, 2018, 126 (01) : 155 - 162
  • [5] Yoga-Specific Enhancement of Quality of Life Among Women With Breast Cancer: Systematic Review and Exploratory Meta-Analysis of Randomized Controlled Trials
    El-Hashimi, Daline
    Gorey, Kevin M.
    JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE, 2019, 24
  • [6] Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer
    Haviland, J. S.
    Hopwood, P.
    Mills, J.
    Sydenham, M.
    Bliss, J. M.
    Yarnold, J. R.
    CLINICAL ONCOLOGY, 2016, 28 (06) : 345 - 353
  • [7] Information needs in breast reconstruction after mastectomy: a qualitative analysis of free-text responses from 2077 women
    Kim Wuyts
    Vicki Durston
    Lisa Morstyn
    Sam Mills
    Victoria White
    Breast Cancer Research and Treatment, 2024, 205 : 147 - 157
  • [8] Information needs in breast reconstruction after mastectomy: a qualitative analysis of free-text responses from 2077 women
    Wuyts, Kim
    Durston, Vicki
    Morstyn, Lisa
    Mills, Sam
    White, Victoria
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (01) : 147 - 157
  • [9] Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials
    Hopwood, Penelope
    Haviland, Joanne S.
    Sumo, Georges
    Mills, Judith
    Bliss, Judith M.
    Yarnold, John R.
    LANCET ONCOLOGY, 2010, 11 (03) : 231 - 240
  • [10] The Effect of Yoga Interventions on Cancer-Related Fatigue and Quality of Life for Women with Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    O'Neill, Meagan
    Samaroo, Dominic
    Lopez, Christian
    Tomlinson, George
    Santa Mina, Daniel
    Sabiston, Catherine
    Culos-Reed, Nicole
    Alibhai, Shabbir M. H.
    INTEGRATIVE CANCER THERAPIES, 2020, 19